WU Duoyi,XU Heping,SUN Juan, et al. Clinical Outcomes and Related Factors of Coronary Microvascular Obstruction in Patients with Delayed Admission after Acute Myocardial Infarction [J]. Chinese General Practice, 2019, 22(13): 1592-1597. DOI: 10.12114/j.issn.1007-9572.2019.00.220.
吴多益,许和平,孙娟等. 急性心肌梗死后就诊延迟患者冠状动脉微血管阻塞的影响因素及临床结局研究[J]. 中国全科医学, 2019, 22(13): 1592-1597. DOI: 10.12114/j.issn.1007-9572.2019.00.220.
[1]MALIK A O,JONES P G,CHAN P S,et al.Association of long-term exposure to particulate matter and ozone with health status and mortality in patients after myocardial infarction[J].Circ Cardiovasc Qual Outcomes,2019,12(4):e005598.DOI:10.1161/CIRCOUTCOMES.119.005598.
[2]SINGH N,RATHORE V,MAHAT R K,et al.Glycogen phosphorylase BB:a more sensitive and specific marker than other cardiac markers for early diagnosis of acute myocardial infarction[J].Indian J Clin Biochem,2018,33(3):356-360.DOI:10.1007/s12291-017-0685-y.
[3]TWERENBOLD R,NEUMANN J T,S?RENSEN N A,et al.Prospective validation of the 0/1-h algorithm for early diagnosis of myocardial infarction[J].J Am Coll Cardiol,2018,72(6):620-632.DOI:10.1016/j.jacc.2018.05.040.
[4]DE CARVALHO L P,TAN S H,OW G S,et al.Plasma ceramides as prognostic biomarkers and their arterial and myocardial tissue correlates in acute myocardial infarction[J].JACC Basic Transl Sci,2018,3(2):163-175.DOI:10.1016/j.jacbts.2017.12.005.
[5]ISHII M,KAIKITA K,SATO K,et al.Cardioprotective effects of LCZ696(sacubitril/valsartan) after experimental acute myocardial infarction[J].JACC Basic Transl Sci,2017,2(6):655-668.DOI:10.1016/j.jacbts.2017.08.001.
[6]ELGENDY I Y,JNEID H.Microvascular obstruction in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention:another frontier to conquer?[J].J Thorac Dis,2018,10(3):1343-1346.DOI:10.21037/jtd.2018.03.58.
[7]FRACASSI F,NICCOLI G.Angiogenesis and microvascular obstruction:still a research topic or a new therapeutic target?[J].Rev Esp Cardiol(Engl Ed),2018,71(6):420-422.DOI:10.1016/j.rec.2017.09.015.
[8]王江友,苏晞.急性心肌梗死患者冠状动脉微血管功能障碍和阻塞机制的研究进展[J].中华老年心脑血管病杂志,2016,18(9):996-998.DOI:10.3969/j.issn.1009-0126.2016.09.026.
WANG J Y,SU X.Research progress of coronary microvascular dysfunction and occlusion mechanism in patients with acute myocardial infarction[J].Chinese Journal of Geriatric Heart Brain and Vessel Diseases,2016,18(9):996-998.DOI:10.3969/j.issn.1009-0126.2016.09.026.
[9]FEISTRITZER H J,REINSTADLER S J,KLUG G,et al.Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction:a prospective,observational study[J].BMC Cardiovasc Disord,2016,16(1):239.DOI:10.1186/s12872-016-0415-z.
[10]MELE D,LUISI G A,PESTELLI G,et al.Echocardiography in ST-elevation myocardial infarction[J].G Ital Cardiol(Rome),2018,19(9):479-487.DOI:10.1714/2951.29666.
[11]BRAVO BAPTISTA S,FAUSTINO M,BRIZIDA L,et al.Early peripheral endothelial dysfunction predicts myocardial infarct extension and microvascular obstruction in patients with ST-elevation myocardial infarction[J].Rev Port Cardiol,2017,36(10):731-742.DOI:10.1016/j.repc.2017.01.006.
[12]KLONER R A.The importance of no-reflow/microvascular obstruction in the STEMI patient[J].Eur Heart J,2017,38(47):3511-3513.DOI:10.1093/eurheartj/ehx288.
[13]HONG N,LEE Y H,TSUJITA K,et al.comparison of the effects of ezetimibe-statin combination therapy on major adverse cardiovascular events in patients with and without diabetes:a meta-analysis[J].Endocrinol Metab(Seoul),2018,33(2):219-227.DOI:10.3803/EnM.2018.33.2.219.
[14]YU F T H,CHEN X,STRAUB A C,et al.The role of nitric oxide during sonoreperfusion of microvascular obstruction[J].Theranostics,2017,7(14):3527-3538.DOI:10.7150/thno.19422.
[15]RíOS-NAVARRO C,HUESO L,MI?ANA G,et al.Coronary serum obtained after myocardial infarction induces angiogenesis and microvascular obstruction repair.Role of hypoxia-inducible factor-1A[J].Rev Esp Cardiol(Engl Ed),2018,71(6):440-449.DOI:10.7150/thno.19422.
[16]STAMBOUL K,ZELLER M,ROCHETTE L,et al.Relation between high levels of myeloperoxidase in the culprit artery and microvascular obstruction,infarct size and reverse remodeling in ST-elevation myocardial infarction[J].PLoS One,2017,12(7):e0179929.DOI:10.1371/journal.pone.0179929.
[17]STIERMAIER T,THIELE H,EITEL I.Coronary microvascular obstruction:key factor in the prognosis of ST-segment-elevation myocardial infarction[J].Circ Cardiovasc Imaging,2017,10(6):e006568.DOI:10.1161/CIRCIMAGING.117.006568.
[18]ZHANG L,MANDRY D,CHEN B,et al.Impact of microvascular obstruction on left ventricular local remodeling after reperfused myocardial infarction[J].J Magn Reson Imaging,2018,47(2):499-510.DOI:10.1002/jmri.25780.
[19]SOEDA T.The mechanism of microvascular obstruction in patients with acute ST-segment elevation myocardial infarction:new light from optical coherence tomography[J].Coron Artery Dis,2017,28(3):188-189.DOI:10.1097/MCA.
[20]GOYAL A,YU F T H,TENWALDE M G,et al.Inertial cavitation ultrasound with microbubbles improves reperfusion efficacy when combined with tissue plasminogen activator in an in vitro model of microvascular obstruction[J].Ultrasound Med Biol,2017,43
(7):1391-1400.DOI:10.1016/j.ultrasmedbio.2017.02.013.
[21]OBER C D,OBER M C,IANCU A C.Serial transthoracic coronary Doppler shows complete reversibility of microvascular obstruction pattern at one month after reperfused acute myocardial infarction[J].Med Ultrason,2017,19(1):45-50.DOI:10.11152/mu-941.
[22]AIHARA H,FUMIKURA Y,NISHINA H.Value of 3-dimensional speckle tracking echocardiography in the prediction of microvascular obstruction and left ventricular remodeling in patients with ST-elevation myocardial infarction[J].Circ J,2017,81(3):353-360.DOI:10.1253/circj.CJ-16-0944.
[23]BULLUCK H,ROSMINI S,ABDEL-GADIR A,et al.Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance[J].Open Heart,2016,3(2):e000535.DOI:10.1136/openhrt-2016-000535.
[24]DE WAHA S,PATEL M R,GRANGER C B,et al.Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction:an individual patient data pooled analysis from seven randomized trials[J].Eur Heart J,2017,38(47):3502-3510.DOI:10.1093/eurheartj/ehx414.
[25]RAHBARI-OSKOUI F F,CHAPMAN A B.Hypoxia-inducible factor 1α(HIF-1α),Angiopoietin-2(ANG-2) and endocan:novel biomarkers of disease progression involving polycystic kidney disease[J].Am J Nephrol,2018,47(4):228-230.DOI:10.1159/000488116.
[26]MA M,DIAO K Y,YANG Z G,et al.Clinical associations of microvascular obstruction and intramyocardial hemorrhage on cardiovascular magnetic resonance in patients with acute ST segment elevation myocardial infarction(STEMI):an observational cohort study[J].Medicine(Baltimore),2018,97(30):e11617.DOI:10.1097/MD.0000000000011617.